Devices › Device, hemostasis, vascular
Device brand name · 8f angio-seal sts plus
8f Angio-Seal Vascular Closure Device Sts Plus: medical device reports filed with FDA
172 reports name it, 2004–2014. Manufacturer given most often on reports: St Jude Medical. Product code MGB.
- 172
- device reports naming the brand
- 0% of all MAUDE reports · about 8 a year
- 0
- reports, 12 months to August 2026
- 0 in the 12 months before
- 1.2%
- classified as malfunction
- 16.4% across the product code
- 4.7%
- classified as death, as reported
- 8 reports · not verified by FDA
FDA's MAUDE database holds 172 reports that name the brand "8f Angio-Seal Vascular Closure Device Sts Plus" (8f angio-seal sts plus), received between June 2004 and July 2014; the manufacturer given most often on reports is St Jude Medical. Spellings of one product vary from report to report.
0 reports arrived in the 12 months to August 2026, and none in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (92.4%), death (4.7%) and other (1.7%); across all device, hemostasis, vascular reports (product code MGB) death is recorded in 0.6% and malfunction in 16.4%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are device remains implanted (20.9%), insufficient device problem information (18%) and explanted (7.6%). The patient problems coded most often are therapy/non-surgical treatment, additional, hematoma and pain. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
No report naming 8f Angio-Seal Vascular Closure Device Sts Plus was received in the five years to August 2026; the latest was received in July 2014.
By year received
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 124,366 reports carrying product code MGB. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| Device remains implanted | 36 | 20.9% | 0.7% |
| Insufficient device problem information | 31 | 18% | 3% |
| Explanted | 13 | 7.6% | 0.7% |
| Malposition of device | 12 | 7% | 3% |
| Breakthe device broke | 5 | 2.9% | 1.5% |
| Device, removal of (non-implant) | 5 | 2.9% | 0.5% |
| Implant, removal of | 5 | 2.9% | 0.2% |
| Replace | 4 | 2.3% | 0.6% |
| Difficult to removethe device was hard to remove | 3 | 1.7% | 4.2% |
| Improper or incorrect procedure or method | 3 | 1.7% | 4.6% |
| Physical resistance | 3 | 1.7% | 0.3% |
| Difficult or delayed positioning | 2 | 1.2% | 1.1% |
| Difficult to position | 2 | 1.2% | 0.5% |
| Entrapment of device | 2 | 1.2% | 1.6% |
| Extrusion | 2 | 1.2% | 0% |
| Failure to advance | 2 | 1.2% | 0.9% |
| Migration or expulsion of device | 2 | 1.2% | 0.3% |
| Bent | 1 | 0.6% | 0.3% |
| Defective devicethe device was defective | 1 | 0.6% | 0.1% |
| Detachment of device component | 1 | 0.6% | 3.4% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| Therapy/non-surgical treatment, additional | 59 | 34.3% |
| Hematomaa collection of blood under the skin or in tissue | 44 | 25.6% |
| Painpain, site not specified | 42 | 24.4% |
| Hospitalization required | 34 | 19.8% |
| Bleeding | 30 | 17.4% |
| Occlusion | 29 | 16.9% |
| Surgical procedure | 25 | 14.5% |
| Hemorrhage/blood loss/bleeding | 18 | 10.5% |
| Stenosis | 18 | 10.5% |
| Treatment with medication(s) | 18 | 10.5% |
| Surgical procedure, additional | 16 | 9.3% |
| Transfusion of blood products | 15 | 8.7% |
| Improved patient condition | 14 | 8.1% |
| Pseudoaneurysm | 13 | 7.6% |
| Swellingswelling | 13 | 7.6% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | 8f Angio-Seal Vascular Closure Device Sts Plus | Product code MGB | All MAUDE reports |
|---|---|---|---|
| Reports | 172 | 124,366 | 26,136,888 |
| Share of that pool | — | 0.1% | 0% |
| Classified as death, per 1,000 reports | 47 | 6 | 9 |
| Classified as injury | 92.4% | 82.5% | 36.2% |
| Classified as malfunction | 1.2% | 16.4% | 62.3% |
| Filed by the manufacturer | 100% | 97.5% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Other brands with product code MGB
| Brand | Reports | Latest 12 months | Classified as death |
|---|---|---|---|
| Perclose Proglide 6f Suture Mediated Closure Smc System | 46,236 | 0 | 0.3% |
| Perclose ProStyle Suture-Mediated Closure and Repair System | 16,441 | 22 | 0% |
| Perclose ProStyle | 12,935 | 2,308 | 0.1% |
| Starclose Se Vascular Closure System | 6,432 | 0 | 0.4% |
| Perclose ProGlide | 3,554 | 653 | 0.9% |
| Angio-Seal | 2,523 | 902 | 0.8% |
| Exoseal | 2,441 | 1,161 | 0% |
| 6f Angio-Seal Vip Vascular Closure Device Ous | 1,818 | 0 | 0.3% |
| Mynx Control | 1,766 | 768 | 0.1% |
| Starclose Vascular Closure System | 1,880 | 8 | 1.2% |
| 6f Angio-Seal Vip Vascular Closure Device Us | 1,617 | 0 | 0.2% |
| Mynxgrip | 1,254 | 422 | 0.3% |
| Prostar Xl Suture-Mediated Closure | 1,239 | 0 | 3.1% |
| Mynxgrip Vascular Closure Device 6f-7f | 1,171 | 0 | 0.6% |
| 8f Angio-Seal Vip Vascular Closure Device Ous | 1,056 | 0 | 0.3% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."
Questions about 8f Angio-Seal Vascular Closure Device Sts Plus reports
How many FDA reports name 8f Angio-Seal Vascular Closure Device Sts Plus?
172 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 0 in the latest 12 months.
What kinds of events are reported?
injury (92.4%), death (4.7%) and other (1.7%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
device remains implanted (20.9%), insufficient device problem information (18%), explanted (7.6%), malposition of device (7%) and break (2.9%). These are FDA's device problem codes as entered on the report.
Who files these reports?
manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that 8f Angio-Seal Vascular Closure Device Sts Plus was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.